287 related articles for article (PubMed ID: 22297643)
1. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
[TBL] [Abstract][Full Text] [Related]
3. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
5. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
6. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
7. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S
J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500
[TBL] [Abstract][Full Text] [Related]
8. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells.
Hirai Y; Iwatsuki K; Takahashi T; Miyake T; Nakagawa Y; Tanimoto S; Kawakami Y; Morizane S
Int J Hematol; 2023 Jul; 118(1):54-64. PubMed ID: 37133637
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
12. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
13. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme.
Yamamoto T; Hirai Y; Miyake T; Yamasaki O; Morizane S; Iwatsuki K
Eur J Dermatol; 2012; 22(3):380-3. PubMed ID: 22361979
[TBL] [Abstract][Full Text] [Related]
14. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.
Wada T; Toga A; Sakakibara Y; Toma T; Hasegawa M; Takehara K; Shigemura T; Agematsu K; Yachie A
Int J Hematol; 2012 Oct; 96(4):443-9. PubMed ID: 22886572
[TBL] [Abstract][Full Text] [Related]
15. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
16. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
18. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease.
Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A
J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
